True Bearing Diagnostics, Inc.

* Over $100 billion potential savings in the US alone by reducing unnecessary slowdown of the economy and education due to emerging pandemics.

• Population Scale Triage Diagnostic:  Rapid diagnostic testing allows identification and quarantine of infected persons.

True Bearing Diagnostics is developing TruNAv, a novel blood RNA-based diagnostic test designed for the early detection of pandemics like COVID19. TruNAv is based on selective capture of immune cells and detecting RNA transcripts that are highly sensitive to Neutrophil Activation by any pathogen, making it an ideal test for the early detection of infections.